Ranbaxy buy triggers Sun Pharma’s Zenotech offer

18th April 2014

Sun Pharmaceutical Industries has made an open offer for Hyderabad-based firm Zenotech Laboratories.

Triggered by its purchase of Ranbaxy Laboratories on April 7. About 64% of Zenotech’s stocks are held by Ranbaxy and its parent company, Daiichi Sankyo, according to shareholding pattern as on March 31.

Read more at source article www.financialexpress.com

Leave a Reply

Your email address will not be published.

43 − 40 =

« back to posts